Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
501
PUT
DELISTED
Allergan plc
AGN
| $45.3M | 0.03% |
269,300
-19,900
| -7% | -$3.24M |
|
|
HES
502
CALL
DELISTED
Hess
HES
| $45M | 0.03% |
744,400
+427,200
| +135% | +$26.6M |
|
|
RTN
503
PUT
DELISTED
Raytheon Company
RTN
| $44.8M | 0.03% |
228,600
+158,900
| +228% | +$29.4M |
|
504
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $44.8M | 0.03% |
849,100
+244,600
| +40% | +$12.8M |
|
505
Sysco
SYY
$40.3B
| $44.7M | 0.03% |
563,088
-866,027
| -61% | -$63.6M |
|
506
CALL
Caterpillar
CAT
$387B
| $44.6M | 0.03% |
353,000
-72,600
| -17% | -$9.22M |
|
507
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
| $44.6M | 0.03% |
1,376,800
+621,200
| +82% | +$19.2M |
|
508
PUT
Occidental Petroleum
OXY
$55.9B
| $44.6M | 0.03% |
1,002,043
+280,743
| +39% | +$13.3M |
|
509
CALL
Cisco
CSCO
$479B
| $44.6M | 0.03% |
901,700
-715,100
| -44% | -$37.2M |
|
|
MDSO
510
DELISTED
Medidata Solutions, Inc.
MDSO
| $44.5M | 0.03% |
486,514
+268,208
| +123% | +$24.5M |
|
511
Dollar Tree
DLTR
$25.2B
| $44.4M | 0.03% |
389,126
-151,740
| -28% | -$15.9M |
|
512
Kroger
KR
$34.8B
| $44.1M | 0.03% |
1,709,109
-613,670
| -26% | -$14.3M |
|
513
CALL
Hilton Worldwide
HLT
$71.5B
| $43.9M | 0.03% |
471,300
-62,700
| -12% | -$5.95M |
|
514
Expeditors International
EXPD
$23.2B
| $43.9M | 0.03% |
590,649
-577,808
| -49% | -$42.3M |
|
515
PUT
Biogen
BIIB
$30.7B
| $43.6M | 0.03% |
187,100
+24,300
| +15% | +$5.66M |
|
516
Boston Properties
BXP
$11.1B
| $43.4M | 0.03% |
334,710
-70,583
| -17% | -$9.17M |
|
|
RODI
517
DELISTED
iPath Return on Disability ETN
RODI
| $43.4M | 0.03% |
500,000
| – | – |
|
|
ZAYO
518
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $43.4M | 0.03% |
1,278,889
+646,868
| +102% | +$21.8M |
|
519
PUT
Merck
MRK
$318B
| $42.9M | 0.03% |
534,690
-173,234
| -24% | -$13.9M |
|
520
PUT
Intuitive Surgical
ISRG
$134B
| $42.9M | 0.03% |
238,500
+30,000
| +14% | +$5.19M |
|
521
Essex Property Trust
ESS
$18.5B
| $42.7M | 0.03% |
130,737
-37,281
| -22% | -$11.7M |
|
522
PUT
Nucor
NUE
$62.1B
| $42.7M | 0.03% |
838,100
+700,400
| +509% | +$36.6M |
|
523
Idexx Laboratories
IDXX
$46.2B
| $42.6M | 0.03% |
156,815
+22,272
| +17% | +$6.2M |
|
524
PUT
Seagate
STX
$184B
| $42.6M | 0.03% |
792,400
-501,300
| -39% | -$24.6M |
|
525
PUT
Amgen
AMGN
$222B
| $42.6M | 0.03% |
220,200
-249,400
| -53% | -$47.9M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.